These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 11692231
1. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes. Bachmann A, Gutcher I, Kopp K, Brendel J, Bosch RF, Busch AE, Gögelein H. Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231 [Abstract] [Full Text] [Related]
2. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current. Lagrutta A, Wang J, Fermini B, Salata JJ. J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807 [Abstract] [Full Text] [Related]
3. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents. Choe H, Lee YK, Lee YT, Choe H, Ko SH, Joo CU, Kim MH, Kim GS, Eun JS, Kim JH, Chae SW, Kwak YG. J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825 [Abstract] [Full Text] [Related]
4. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations. Caballero R, Gómez R, Núñez L, Moreno I, Tamargo J, Delpón E. Cardiovasc Res; 2004 Dec 01; 64(3):457-66. PubMed ID: 15537499 [Abstract] [Full Text] [Related]
5. Expression of voltage-gated K+ channels in human atrium. Bertaso F, Sharpe CC, Hendry BM, James AF. Basic Res Cardiol; 2002 Nov 01; 97(6):424-33. PubMed ID: 12395204 [Abstract] [Full Text] [Related]
6. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes. Fedida D, Eldstrom J, Hesketh JC, Lamorgese M, Castel L, Steele DF, Van Wagoner DR. Circ Res; 2003 Oct 17; 93(8):744-51. PubMed ID: 14500335 [Abstract] [Full Text] [Related]
7. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5. Perchenet L, Clément-Chomienne O. J Pharmacol Exp Ther; 2000 Nov 17; 295(2):771-8. PubMed ID: 11046117 [Abstract] [Full Text] [Related]
8. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5. Peukert S, Brendel J, Pirard B, Brüggemann A, Below P, Kleemann HW, Hemmerle H, Schmidt W. J Med Chem; 2003 Feb 13; 46(4):486-98. PubMed ID: 12570371 [Abstract] [Full Text] [Related]
9. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels. Yang IC, Scherz MW, Bahinski A, Bennett PB, Murray KT. J Pharmacol Exp Ther; 2000 Sep 13; 294(3):955-62. PubMed ID: 10945846 [Abstract] [Full Text] [Related]
14. Effects of protein kinase C on delayed rectifier K+ channel regulation by tyrosine kinase in rat retinal pigment epithelial cells. Strauss O, Rosenthal R, Dey D, Beninde J, Wollmann G, Thieme H, Wiederholt M. Invest Ophthalmol Vis Sci; 2002 May 13; 43(5):1645-54. PubMed ID: 11980886 [Abstract] [Full Text] [Related]
16. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization. Moreno I, Caballero R, González T, Arias C, Valenzuela C, Iriepa I, Gálvez E, Tamargo J, Delpón E. J Pharmacol Exp Ther; 2003 Feb 13; 304(2):862-73. PubMed ID: 12538844 [Abstract] [Full Text] [Related]
17. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Crumb WJ, Wible B, Arnold DJ, Payne JP, Brown AM. Mol Pharmacol; 1995 Jan 13; 47(1):181-90. PubMed ID: 7838127 [Abstract] [Full Text] [Related]
18. Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide. Hanada E, Ohtani H, Hirota M, Uemura N, Nakaya H, Kotaki H, Sato H, Yamada Y, Iga T. J Pharm Pharmacol; 2003 Jul 13; 55(7):995-1002. PubMed ID: 12906757 [Abstract] [Full Text] [Related]